AAAAAA

   
Results: 1-8 |
Results: 8
Sociodemographic and clinical predictors of participation in two randomized trials: Findings from the collaborative ocular melanoma study COMS ReportNo. 7
Authors: Diener-West, M Hawkins, BS Moy, CS Earle, JD
Citation: M. Diener-west et al., Sociodemographic and clinical predictors of participation in two randomized trials: Findings from the collaborative ocular melanoma study COMS ReportNo. 7, CONTR CL TR, 22(5), 2001, pp. 526-537
A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy
Authors: Gorman, CA Garrity, JA Fatourechi, V Bahn, RS Petersen, IA Stafford, SL Earle, JD Forbes, GS Kline, RW Bergstralh, EJ Offord, KP Rademacher, DM Stanley, NM Bartley, GB
Citation: Ca. Gorman et al., A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy, OPHTHALMOL, 108(9), 2001, pp. 1523-1534
Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16
Authors: Melia, BM Abramson, DH Albert, DM Boldt, HC Earle, JD Hanson, WF Montague, P Moy, CS Schachat, AP Simpson, ER Straatsma, BR Vine, AK Weingeist, TA
Citation: Bm. Melia et al., Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma - I. Visual acuity after 3 years - COMS report no. 16, OPHTHALMOL, 108(2), 2001, pp. 348-366
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled
Authors: Diener-West, M Earle, JD Fine, SL Hawkins, BS Moy, CS Reynolds, SM Schachat, AP Straatsma, BR
Citation: M. Diener-west et al., The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled, ARCH OPHTH, 119(7), 2001, pp. 951-965
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings
Authors: Diener-West, M Earle, JD Fine, SL Hawkins, BS Moy, CS Reynolds, SM Schachat, AP Straatsma, BR
Citation: M. Diener-west et al., The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings, ARCH OPHTH, 119(7), 2001, pp. 969-982
Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy
Authors: Chou, RH Wilder, RB Ji, M Ryu, JK Leigh, BR Earle, JD Doggett, RLS Kubo, HD Roach, M White, RWD
Citation: Rh. Chou et al., Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy, INT J RAD O, 47(1), 2000, pp. 115-119
Preliminary results of three-dimensional conformal radiotherapy as salvagetreatment for a rising prostate-specific antigen level postprostatectomy
Authors: Wilder, RB Hsiang, JY Ji, M Earle, JD White, RD
Citation: Rb. Wilder et al., Preliminary results of three-dimensional conformal radiotherapy as salvagetreatment for a rising prostate-specific antigen level postprostatectomy, AM J CL ONC, 23(2), 2000, pp. 176-180
Results from the collaborative ocular melanoma study (COMS) of enucleationversus preoperative radiation therapy in the management of large ocular melanomas
Authors: Earle, JD
Citation: Jd. Earle, Results from the collaborative ocular melanoma study (COMS) of enucleationversus preoperative radiation therapy in the management of large ocular melanomas, INT J RAD O, 43(5), 1999, pp. 1168-1169
Risultati: 1-8 |